Skip to main content
. 2022 Sep 5;29(1):135–145. doi: 10.3350/cmh.2022.0181

Figure 1.

Figure 1.

Consolidated Standards of Reporting Trials diagram. cACLD, compensated advanced chronic liver disease; HCC, hepatocellular carcinoma; LSM, liver stiffness measurement; NSBB, non-selective beta-blocker; CSPH, clinically significant portal hypertension.